Author:
Patties Ina,Jahns Jutta,Hildebrandt Guido,Kortmann Rolf-Dieter,Glasow Annegret
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Radiology Nuclear Medicine and imaging
Reference41 articles.
1. Aparicio A, Eads CA, Leong LA, et al. I trial of continuous infusion 5-aza-2′-deoxycytidine. Cancer Chemother Pharmacol 2003;51:231–9.
2. Appleton K, Mackay HJ, Judson I, et al. Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors. J Clin Oncol 2007;25:4603–9.
3. Atallah E, Kantarjian H, Garcia-Manero G. The role of decitabine in the treatment of myelodysplastic syndromes. Expert Opin Pharmacother 2007;8: 65–73.
4. Chabot GG, Rivard GE, Momparler RL. Plasma and cerebrospinal fluid pharmacokinetics of 5-aza-2′-deoxycytidine in rabbits and dogs. Cancer Res 1983;43:592–7.
5. Chai G, Li L, Zhou W, et al. HDAC inhibitors act with 5-aza-2′-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells. PLoS ONE 2008;3:e2445.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献